Expression of CC chemokine ligand 5 in patients with rheumatoid arthritis and its correlation with disease activity and medication

Chinese Medical Sciences Journal

Volumn 24, Issue 1, 2009, Pages 50-54

  Yang, Ming Hui ^a   Wu, Feng Xia ^a   Xie, Chuan Mei ^a   Qing, Yu Feng ^a   Wang, Guang Rong ^a   Guo, Xiao Lan ^a   Tang, Zhong ^a   Zhou, Jing Guo ^a   Yuan, Guo Hua ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

CC chemokine ligand 5; Chemokine; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HERBACEOUS AGENT; RANTES; TRIPTERYGIUM GLUCOSIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE MARKER; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

EID: 64949147990     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(09)60059-6     Document Type: Article

References (17)

1. Iwamoto T, Okamoto H, Toyama Y, et al. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 2008; 275:4448-55.
2. Filer A, Raza K, Salmon M, et al. The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis. Front Biosci 2008; 13:2674-85.
3. Karlmark KR, Wasmuth HE, Trautwein C, et al. Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2008; 2:233-42.
4. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
5. Yuan GH, Masuko-Hongo K, Nishioka K. Role of chemokines/chemokine receptor systems in cartilage degradation. Drug News Perspect 2001; 14:591-600.
6. Ruth JH, Rottman JB, Katschke KJ Jr, et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001; 44:2750-60.
7. Pharoah DS, Varsani H, Tatham RW, et al. Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells. Arthritis Res Ther 2006; 8:R50.
8. Haas CS, Martinez RJ, Attia N, et al. Chemokine receptor expression in rat adjuvant-induced arthritis. Arthritis Rheum 2005; 52:3718-30.
9. Shahrara S, Proudfoot AE, Woods JM, et al. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 2005; 52:1907-19.
10. Barsante MM, Cunha TM, Allegretti M, et al. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Br J Pharmacol 2008; 153: 992-1002.
11. Torikai E, Kageyama Y, Suzuki M, et al. The effect of infliximab on chemokines in patients with rheumatoid arthritis. Clin Rheumatol 2007; 26:1088-93.
12. Lee YR, Kweon SH, Kwon KB, et al. Inhibition of IL-1beta-mediated inflammatory responses by the IkappaB alpha super-repressor in human fibroblast-like synoviocytes. Biochem Biophys Res Commun 2009; 378:90-4.
13. Konig A, Krenn V, Toksoy A, et al. Mig, GRO alpha and RANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Virchows Arch 2000; 436: 449-58.
14. Volin MV, Shah MR, Tokuhira M, et al. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 1998; 89:44-53.
15. Boiardi L, Macchioni P, Meliconi R, et al. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol 1999; 17:419-25.
16. Yao TC, Kuo ML, See LC, et al. RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Arthritis Rheum 2006; 54:2585-93.
17. Barsig J, Yam G, Lehner MD, et al. Methotrexate treatment suppresses local cytokine and chemokine production in rat adjuvant arthritis. Drugs Exp Clin Res 2005; 31:7-11.